Araki Hiroaki, Kawakami Ken-ya, Jin Chunyu, Suemaru Katsuya, Kitamura Yoshihisa, Nagata Mari, Futagami Koujiro, Shibata Kazuhiko, Kawasaki Hiromu, Gomita Yutaka
Division of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Shigenobu-cho, 791-0295 Ehime, Onsen-gun, Japan.
Psychopharmacology (Berl). 2004 Feb;171(4):398-404. doi: 10.1007/s00213-003-1595-7. Epub 2003 Sep 10.
Acute physical dependence refers to the withdrawal syndrome precipitated by an opioid antagonist administered several hours after either a single dose or a short-term infusion of an opioid agonist.
We examined the mechanism of nicotine-induced attenuation of naloxone-precipitated withdrawal syndrome when used to produce an aversive motivational state in a place-conditioning paradigm.
The effect of nicotine was investigated through place aversion induced by naloxone in morphine-pretreated rats. Additionally, the mechanism of nicotine action in this model was explored specifically in relation to the dopaminergic system through the use of dopamine receptor antagonist and agonist.
Place avoidance behavior was potently elicited by naloxone (0.5 mg/kg s.c.) 24 h after a single exposure to morphine (10 mg/kg s.c.). Avoidance behavior was attenuated by pretreatment with a 0.2-mg/kg dose of nicotine 15 min prior to naloxone administration. The effect of nicotine was completely blocked by mecamylamine, but not hexamethonium. The dopamine receptor antagonists haloperidol (0.05, 0.1 mg/kg, s.c.), SCH23390 (0.1 mg/kg, s.c.), raclopride (1.0 mg/kg, s.c.) and eticlopride (0.1 mg/kg, s.c.) showed effects similar to mecamylamine. Additionally, the dopamine receptor agonist apomorphine (0.03, 0.1, 0.3 mg/kg, s.c.) inhibited naloxone-induced place aversion in morphine-treated rats.
The inhibitory effect of nicotine on place aversion induced by naloxone-precipitated morphine withdrawal may involve a dopaminergic portion of the central nervous system.
急性身体依赖性是指在单次给药或短期输注阿片类激动剂数小时后给予阿片类拮抗剂所引发的戒断综合征。
我们研究了在位置条件反射范式中用于产生厌恶动机状态时,尼古丁对纳洛酮诱发的戒断综合征的抑制机制。
通过纳洛酮在吗啡预处理大鼠中诱导的位置厌恶来研究尼古丁的作用。此外,通过使用多巴胺受体拮抗剂和激动剂,特别探讨了该模型中尼古丁作用与多巴胺能系统相关的机制。
单次皮下注射吗啡(10mg/kg)24小时后,皮下注射纳洛酮(0.5mg/kg)能有效诱发位置回避行为。在纳洛酮给药前15分钟,预先给予0.2mg/kg剂量的尼古丁可减弱回避行为。尼古丁的作用被美加明完全阻断,但六甲铵未起作用。多巴胺受体拮抗剂氟哌啶醇(0.05、0.1mg/kg,皮下注射)、SCH23390(0.1mg/kg,皮下注射)、雷氯必利(1.0mg/kg,皮下注射)和依替必利(0.1mg/kg,皮下注射)显示出与美加明相似的效果。此外,多巴胺受体激动剂阿扑吗啡(0.03、0.1、0.3mg/kg,皮下注射)可抑制纳洛酮在吗啡处理大鼠中诱发的位置厌恶。
尼古丁对纳洛酮诱发的吗啡戒断所致位置厌恶的抑制作用可能涉及中枢神经系统的多巴胺能部分。